Results 61 to 70 of about 10,335 (173)

Predicting Post-Operative Outcomes in CTEPH Patients [PDF]

, 2020
Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is characterized by thromboembolic material blocking the pulmonary vasculature, which results in elevated pulmonary pressure and vascular resistance.
Kabu, Shradha
core   +1 more source

Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Ring finger protein 213 (RNF213) p.Arg4810Lys is a susceptibility gene for moyamoya disease, peripheral pulmonary artery stenosis (PPS), and other vascular diseases and thrombosis. We investigated the prevalence and clinical characteristics of
Takatoyo Kiko, Ryotaro Asano, Tomohiko Ishibashi, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Yoshikazu Nakaoka, Takeshi Ogo   +10 more
doaj   +1 more source

Chronic thromboembolic pulmonary hypertension: a distinct disease entity

European Respiratory Review, 2015
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct subtype of pulmonary hypertension (PH). One disease hypothesis is that CTEPH results from the non-resolution of venous thromboembolism.
Irene Lang
doaj   +1 more source

Navigating the Complexities of Pulmonary Hypertension Care: Unique Challenges in PAH Management

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Pulmonary hypertension (PH) comprises a heterogeneous group of disorders characterized by elevated pressure in the pulmonary arteries. Despite advances in awareness, utilization of non‐invasive screening with echocardiography, increasing number of targeted therapies, and evolving clinical guidelines emphasizing referral to PH specialty centers,
Karla Cruz Morel, Namita Sood, Roberto Bernardo, Kimberly Jackson, Gillian P. Leung, Charles Burger, Jean M. Elwing   +6 more
wiley   +1 more source

Rare variants in STAB2 in patients with chronic thromboembolic pulmonary hypertension

ERJ Open Research
Background The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is poorly understood. Studies of the genetic risk factors for CTEPH are likely to improve our understanding of CTEPH pathogenesis and may lead to novel treatment and ...
Mark W. Dodson, Kristina Allen-Brady, Jeffrey Stevens, Meghan M. Cirulis, Mona Alotaibi, Timothy M. Fernandes, Nick H. Kim, Kim M. Kerr, Demosthenes G. Papamatheakis, David S. Poch, Julianna Desmarais, D. Hunter Best, Nathan D. Hatton, John J. Ryan, C. Gregory Elliott, Lisa A. Cannon-Albright   +15 more
doaj   +1 more source

Metabolic Markers as Potential Risk Factors in Pulmonary Hypertension

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Pulmonary hypertension (PH) is a condition characterized by elevated mean pulmonary arterial pressure confirmed by right heart catheterization. PH involves both structural and functional changes in the pulmonary vascular bed. Since 2022, a four‐level risk stratification has been used to predict 1‐year mortality at follow‐up.
Sarah McGarrity, Pär I Johansson, Jørn Carlsen   +2 more
wiley   +1 more source

Chronic thromboembolic pulmonary hypertension

Swiss Medical Weekly, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially fatal disease, which may occur as a rare complication after acute pulmonary embolism, although the exact epidemiology of CTEPH is unknown.
Isabelle Opitz, Silvia Ulrich
doaj   +1 more source

DEGs between CTEPH group and IPAH group.

(A) Volcano plot illustrating the differential expression of genes between the CTEPH and IPAH groups. Red dots represent up-regulated genes, while green dots represent down-regulated genes.
Liu Wang (213066), Shizhang Zhan (18120962), Ruoran Li (11652139), Wenping Wang (440405)   +3 more
core   +1 more source

Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension

Thrombosis Journal
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease with poor outcome if left untreated. Identifying patients at risk of CTEPH already at acute pulmonary embolism (APE) would lead to earlier goal-directed management.
Olga Dzikowska-Diduch, Iwona Dudzik-Niewiadomska, Katarzyna Kurnicka, Barbara Lichodziejewska, Katarzyna Perzanowska-Brzeszkiewicz, Mateusz Kuropatwa, Andrzej Łabyk, Marek Roik, Dariusz Zieliński, Marek Gołębiowski, Piotr Pruszczyk   +10 more
doaj   +1 more source

Filtered GO categories for potential pathogenesis of CTEPH.

, 2014
Filtered GO categories for potential pathogenesis of CTEPH.
Huili Gan (590522), Jason X.-J. Yuan (270715), Chen Wang (88408), Jie Liu (15128), Yuanhua Yang (340621), Lijuan Guo (404771), Song Gu (590521), Jun Cai (157029), Jun Wang (5906), Lei Wang (6656), Yan Liu (25061), Jifeng Li (590520), Ying Wang (11406)   +12 more
core   +1 more source